KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Cash from Financing Activities: 2019-2025

Historic Cash from Financing Activities for Hims & Hers Health (HIMS) over the last 6 years, with Sep 2025 value amounting to -$39.0 million.

  • Hims & Hers Health's Cash from Financing Activities fell 0.49% to -$39.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $813.5 million, marking a year-over-year increase of 928.77%. This contributed to the annual value of -$107.8 million for FY2024, which is 839.83% down from last year.
  • Latest data reveals that Hims & Hers Health reported Cash from Financing Activities of -$39.0 million as of Q3 2025, which was down 104.39% from $889.2 million recorded in Q2 2025.
  • In the past 5 years, Hims & Hers Health's Cash from Financing Activities registered a high of $889.2 million during Q2 2025, and its lowest value of -$39.0 million during Q3 2025.
  • Moreover, its 3-year median value for Cash from Financing Activities was -$13.7 million (2024), whereas its average is $64.3 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first tumbled by 13,308.97% in 2022, then surged by 3,647.45% in 2025.
  • Quarterly analysis of 5 years shows Hims & Hers Health's Cash from Financing Activities stood at -$78,000 in 2021, then slumped by 13,308.97% to -$10.5 million in 2022, then soared by 62.11% to -$4.0 million in 2023, then plummeted by 244.49% to -$13.7 million in 2024, then declined by 0.49% to -$39.0 million in 2025.
  • Its Cash from Financing Activities stands at -$39.0 million for Q3 2025, versus $889.2 million for Q2 2025 and -$23.0 million for Q1 2025.